
Mbix Pharmaceuticals Private Limited
About Mbix Pharmaceuticals Private Limited
Data last updated:
Mbix Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the artificial fibres segment of the food and beverages sector. It was incorporated on 19 February 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24303BR2019PTC041073. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Vandana Kumari (Whole-Time Director) and Sanjay Kumar (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at 1st Floor J/146 P C Colony Kankarbagh, Patna, Bihar, India – 800020.
As per the financials filed for FY 2021, the company reported a revenue of ₹2.71 Lakh, a growth of 144% compared to the previous year. For the same year it recorded a net loss of ₹2.57 Lakh (net margin -94.8%) and EBITDA of -₹2.52 Lakh (EBITDA margin -93.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mbix Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address is in the company report.
- Email
- Registered Address1st Floor J/146 P C Colony Kankarbagh, Patna, Bihar, India – 800020
- IndustryFood And Beverages, Artificial Fibres, Manufacturing
To see the full contact details of Mbix Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mbix Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mbix Pharmaceuticals Private Limited, buy the company report.
Financials of Mbix Pharmaceuticals Private Limited
FY 2021 filings availableMbix Pharmaceuticals Private Limited reported revenue of ₹2.71 Lakh (up 144% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue rose 144% in the latest year. EBITDA rose 35% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹2.52 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹2.57 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -93.2% | ||
| Net Profit Margin | -94.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Mbix Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mbix Pharmaceuticals Private Limited
Mbix Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vandana Kumari | Whole-Time Director | 19 Feb 2019 | 7 Years 8 Months | Current |
| Sanjay Kumar | Whole-Time Director | 19 Feb 2019 | 7 Years 8 Months | Current |
Peer comparison
Mbix Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| RX Vision Care Pharmaceuticals Private Limited | ₹2.72 Lakh (FY 2021) | -68.0% | Jaipur, Rajasthan, India | |||
| Viashvi Pharmaceuticals Private Limited | ₹2.72 Lakh (FY 2024) | -67.0% | Amethi, Uttar Pradesh, India | |||
| Mbix Pharmaceuticals Private Limitedthis company | ₹2.71 Lakh (FY 2021) | -₹2.57 Lakh | -94.8% | 144.0% | Patna, Bihar, India | |
| Reverie Pharmaceuticals Private Limited | ₹2.7 Lakh (FY 2025) | -33.0% | Ahmedabad, Gujarat, India | |||
| Exlr Pharmaceuticals Private Limited | ₹2.68 Lakh (FY 2024) | 84.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Mbix Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mbix Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mbix Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mbix Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Mbix Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mbix Pharmaceuticals Private Limited has 2 board changes on record since 2019: 2 appointments. The latest: Sanjay Kumar was appointed as Whole-Time Director on 19 Feb 2019.
Frequently asked questions
Mbix Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in artificial fibres, within the food and beverages industry. It was incorporated on 19 February 2019 (7+ years old) and is registered under CIN U24303BR2019PTC041073.
Mbix Pharmaceuticals has 2 current directors:
- Vandana Kumari - Whole-Time Director
- Sanjay Kumar - Whole-Time Director
The latest financial statements of Mbix Pharmaceuticals on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2019 are in the company report.
No. Mbix Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Mbix Pharmaceuticals is U24303BR2019PTC041073. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mbix Pharmaceuticals was incorporated on 19 February 2019, making it 7+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Mbix Pharmaceuticals by revenue are RX Vision Care Pharmaceuticals Private Limited, Viashvi Pharmaceuticals Private Limited, Reverie Pharmaceuticals Private Limited, Exlr Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Sanjay Kumar was appointed as Whole-Time Director on 19 Feb 2019. Vandana Kumari was appointed as Whole-Time Director on 19 Feb 2019.
The registered office of Mbix Pharmaceuticals is at 1st Floor J146 P C Colony Kankarbagh, Patna, Bihar, India – 800020.
Mbix Pharmaceuticals operates in the food and beverages industry, in the artificial fibres segment.
The compliance status of Mbix Pharmaceuticals is compliant as of 06 September 2026. The company is actively filing with the Registrar of Companies.

